In the realm of biochemical research and laboratory analysis, the pth 1 34 peptide stands out a Synthetic human parathyroid hormone 1-34 fragment for s a subject of significant interest. As a frequent observer of peptide research trends, I have found that understanding the structural and functional nuances of this specific fragment is essential for anyone delving into endocrine-related studies.
Structural Composition and Biological Role
At its core, PTH (1-34) is a peptide fragment consisting of the N-terminal 34 amino acid residues of the full-length, 84-amino-acid parathyroid hormone. This specific sequence is a human parathyroid h Parathyroid Hormone (PTH) (1-34) (Bovine) ormone (hPTH) peptide fragment that retains the primary bio PTH (13-34) Human - Hormones logical activity of the native molecule.
The native hormone is an 84 amino acid peptide hormone primarily responsible for ma Parathyroid hormone (1-34) (human) intaining calcium homeostasis. By focusing on the N-terminal 1-34 region, researchers can isolate the domain that acts as a potent PTH receptor agonist, particularly concerning the PTH1 and PTH2 receptors which are highly expressed in bone and kidney cells.
Applications in Research and Assays
When sourcing these compounds, quality is paramount. I have noted that high-purity Parathyroid hormone (1-34) (human) peptide is critical for ensuring reliable results in laboratory settings. This specific sequence is suitable for use in ELISA, Western Blot, Dot blot, PCA, and other assays.
Many researchers utilize this peptide to study cellular signaling pathways. For instance, it has been observed that PTH (1-34) reflects the highest cAMP produced by this peptide in various cell lines, making it a gold standard for studying G-protein coupled receptor activation. Furthermore, researchers often look for specialized versions, such as Biotin-Parathyroid Hormone (1-34), to facilitate tracking and binding studies.
Insights into Bone Turnover and Homeostasis
One of the most compelling aspects of this peptide is its role in skeletal research. It is widely recognized as one of the key stimulators of bone turnover. Specifically, the terminal 34 residues of parathyroid hormone are known to exhibit an anabolic effect, which is why this fragment has been shown to promote bone formation in controlled experimental models.
T Parathyroid hormone (PTH) is an 84 amino acid hormone involved in calcium regulation in counteraction to calcitonin.PTH regulates serum phosphate levelsRead more his resea Parathyroid Hormone (1-34) (rat) (acetate) rch is vital for those investigating the mechanisms of skeletal health, often utilized in studies where researchers can be used for th r Parathyroid Hormone (PTH) (1-34), human eseach of osteoporosis. Beyond bone, the peptide’s influence is broad; it is a critical molecule because PTH regulates serum phosphate levels and plays a complex role in systemic mineral balance. Interestingly, some studies suggest that PTH(1--34) administration suppresses cardiovascular calcification and modulates aortic osteogenic programs, highlighting its diverse physiological implications.
Comparative Biochemistry: PTH vs. PTHrP
PTH (1-34) (human) | Parathyroid hormone | TeriparatideIn my review of the literature, I often see comparisons between PTH and PTH-related polypeptide (PTHrP). While they share signaling pathways, their physiological roles differ. For example, while PTH is central to calcium regulation, PTHrP is abundant in the central nervous system, though its specific functions there remain a subject of ongoing investigation. When comparing these substances, researchers often look at the sequence alignment of PTH(1–34) and PTHrP(1–36) to understand how minor structural changes influence receptor affinity.
Summary of Laboratory Observations
For those interested in the technical specifications, pTH (1-34) (human) is often synthesized to mirror Teriparatide, which consists of the N-terminal 34 amino acid residues of parathyroid hormone. Whether one is investigating PTH 1-34 for its receptor-binding properties or exploring novel variants like PTH 13-34, the focus remains on the precise interaction between the peptide and its biological targets.
As the field evolves, the push to develop a long-acting PTH1–34 analogue continues to drive innovation, promising to enhance the stability and efficacy of these molecules in future research applications. By maintaining a focus on high-purity peptides and rigorous experimental design, the scientific community continues to uncover the intricate ways these fragments influence bone and mineral physiology.